LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als

World's First Inhalable COVID-19 Vaccine Approved in China - COVID-19 - mobile.

Japan's Daiichi Sankyo to make mRNA vaccine pillar of business - Nikkei Asia

Japan's Daiichi Sankyo to make mRNA vaccine pillar of business - Nikkei Asia

Purified Rat Anti-Human IL-10

PharmaCompass – Grow Your Pharma Business Digitally

Anima Biotech - mRNA Lightning Platform

JCI - Article_in_issue

Daiichi Sankyo to supply omicron XBB.1.5-adapted COVID-19 vaccine in Japan

Anima Biotech - Company info. interviews, news

AbbVie to Develop mRNA Modulators Using Anima Biotech Platform

BioSpectrum Asia Jan 2023 - Flip eBook Pages 1-50

Anima Biotech - mRNA Lightning Platform

Sponsor Detail Template – Chinese American Biopharmaceutical Society

China Accelerating Development of its First Homegrown mRNA Covid Vaccine - Bloomberg

A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia